EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A

Jens Müller iD, Thilo Albert, Claudia Klein, Silvia Horneff, Heiko Rühl, Bernd Pötzsch, Georg Goldmann, Natascha Marquardt, Johannes Oldenburg iD

Haemophilia · 2024-09 · 30 (5) · 1203-1209

DOI: 10.1111/hae.15089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, online erschienen am 20.08.2024. Verfasst von Jens Müller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lonoctocog alfa is a single‐chain factor VIII (FVIII) molecule with high binding affinity to von‐Willebrand‐factor. While it is well known that its plasma activity is underestimated by one‐stage clotting assays (OSCA), there is a lack of knowledge on the post‐infusion performance of lonoctocog alfa in global coagulation assays or its potential impact on the haemostatic balance in vivo.

Aim

To characterize lonoctocog alfa versus octocog alfa in pre‐ and post‐infusion samples obtained from patients undergoing repeated investigation of incremental recovery (IR).

Methods

Eighteen patients with severe haemophilia A (lonoctocog alfa: 10, octocog alfa: 8) were included. A panel of factor‐specific and global coagulation assays was applied, comprising a FVIII OSCA, two FVIII chromogenic substrate assays (CSA), rotational thrombelastography and thrombin generation (TG). Potential activation of coagulation was assessed by measuring plasma thrombin markers and levels of activated protein C.

Results

Comparable IRs were found for lonoctocog alfa and octocog alfa (2.36 [IU/dL]/[IU/kg] vs. 2.55 [IU/dL]/[IU/kg], respectively). Lonoctocog alfa activities were found to be underestimated by the FVIII OSCA while also the two FVIII CSAs showed statistically significant assay discrepancies on lonoctocog alfa. Effects of both FVIII products on rotational thrombelastography were less distinct than those on TG parameters. No elevated pre‐ or significantly shifting post‐infusion plasma levels of coagulation biomarkers were detected.

Conclusion

Lonoctocog alfa and octocog alfa showed comparable recovery and safety in vivo as well as similar impacts on TG in vitro. Observed assay discrepancies on lonoctocog alfa demonstrated variability of results also between different FVIII CSAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AFactor VIIIHumansAdultMaleBlood Coagulation TestsYoung AdultAdolescentMiddle AgedBlood Coagulation

Stichwörter der Autor:innen

assay discrepanciescoagulation biomarkerslonoctocog alfaoctocog alfathrombin generation

Substanzen

Factor VIII

Autor:innen und Institutionen

  • Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.

ORCID-Profile: Jens Müller, Johannes Oldenburg

Förderung

  • CSL Behring

Zitieren

APA

Müller, J., Albert, T., Klein, C., Horneff, S., Rühl, H., Pötzsch, B., Goldmann, G., Marquardt, N., & Oldenburg, J. (2024). Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A. Haemophilia, 30(5), 1203-1209. https://doi.org/10.1111/hae.15089

Vancouver

Müller J, Albert T, Klein C, Horneff S, Rühl H, Pötzsch B, et al. Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A. Haemophilia. 2024;30(5):1203-1209. doi:10.1111/hae.15089

BibTeX
@article{Mller2024,
  author = {Müller, Jens and Albert, Thilo and Klein, Claudia and Horneff, Silvia and Rühl, Heiko and Pötzsch, Bernd and Goldmann, Georg and Marquardt, Natascha and Oldenburg, Johannes},
  title = {Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A},
  journal = {Haemophilia},
  year = {2024},
  volume = {30},
  number = {5},
  pages = {1203--1209},
  doi = {10.1111/hae.15089}
}
Kostenlos starten →